Abstract
Background: Alaska Native people currently have a higher prevalence of hypertension than do nonnative Alaskans, although in the 1950s hypertension was rare among Alaska Native people. A novel biomarker of marine foods, the nitrogen isotope ratio (δ15N) in RBCs was shown to be negatively associated with systolic and diastolic blood pressure. Few studies have examined how individual characteristics modify the association of marine food intake with blood pressure.
Objective: This exploratory analysis examined whether sex, adiposity, and hypertension modify the inverse association between marine food intake and blood pressure.
Methods: We used covariate-adjusted linear models to describe the association between δ15N and blood pressure in 873 adult Alaska Native (Yup’ik) people who resided in 8 communities in southwest Alaska. We separately stratified by sex, body mass index (BMI) group, abdominal obesity, and hypertension status and assessed the interaction between δ15N and participant characteristics on blood pressure via likelihood ratio tests.
Results: The association between δ15N and systolic blood pressure was modified by sex, BMI status, and abdominal obesity, with the inverse association observed only in the male (β = −1.5; 95% CI: −2.4, −0.6), nonobese BMI (β = −1.7; 95% CI: −2.5, −1.0), and non–abdominally obese (β = −1.6; 95% CI: −2.4, −0.9) strata (all P-interaction < 0.0001). A reduction in diastolic blood pressure associated with δ15N was observed in the nonobese BMI (β = −1.1; 95% CI: −1.7, −0.5) and non–abdominally obese (β = −1.1; 95% CI: −1.7, −0.5) strata, although only the interaction between BMI group and δ15N with diastolic blood pressure was significant. The inverse association between δ15N and both systolic and diastolic blood pressure was observed in nonhypertensive individuals, although the comparison had limited power. The results were consistent with those identified by using combined RBC concentrations of eicosapentaenoic acid and docosahexaenoic acid as the biomarker of marine food intake, although the associations identified by using δ15N were larger.
Conclusions: Obesity status modified the inverse association between marine food intake and both systolic and diastolic blood pressure in adult Alaska Native (Yup’ik) people. The inverse association between δ15N and systolic blood pressure was also modified by sex.
Keywords: biomarker, effect modification, hypertension, indigenous people, marine food intake
Introduction
Alaska Native people currently have a higher prevalence of hypertension than do nonnative Alaskans (1), although in the 1950s hypertension was rare among Alaska Native people (2, 3). Increased access to market foods has substantially affected the nutritional intake of Alaska Native people. For example, in the Yup’ik people, one of the most numerous of the Alaska Native groups, macronutrient intake has shifted from a traditional dietary pattern of low carbohydrate, high protein, and high fat to a high-carbohydrate pattern that is similar to that observed in a US national sample (1, 4, 5). The Center for Alaska Native Health Research (CANHR), established in 2001, has been investigating protective factors and correlates of chronic metabolic disease risk in the Yup’ik people of southwest Alaska (6).
CANHR’s efforts have been focused primarily in the Yukon-Kuskokwim Delta region of Alaska, where there are ∼23,000 Yup’ik individuals inhabiting 58 rural villages, none of which are accessible by roads (4). The Yup’ik diet includes a combination of traditional and Western foods (7), with traditional foods contributing 22% of total calories (5). Marine food sources, primarily fish and seal oil, contributed 69% of energy intake to the traditional component of the Yup’ik diet (5).
CANHR has been developing objective biomarkers of traditional intake based on stable isotope ratios in order to reduce the bias and error associated self-reported measures (8, 9). The nitrogen stable isotope ratio of 15N to 14N (δ15N; as defined in Methods) in RBCs is a specific marker of marine protein and has been shown to be a reliable marker of overall marine food intake. RBC δ15N is significantly correlated with self-reported measures of marine food intake as well as with RBC concentrations of EPA (20:5n–3) and DHA (22:6n–3) (r = 0.83 and 0.75, respectively) (4, 6). The use of δ15N instead of EPA and DHA as a biomarker of marine intake has the advantage of having higher throughput and lower cost.
Our group previously evaluated the association between 3 biomarkers of marine food intake, specifically RBC EPA, DHA, and δ15N and systolic and diastolic blood pressure in a cohort of Yup’ik people (10). δ15N was shown to be inversely associated with systolic (β = −0.97, P = 0.02) and diastolic (β = −0.92, P ≤ 0.01) blood pressure; EPA exhibited similar associations. This study did not, however, examine whether the association differed by individual characteristics such as sex, obesity, and clinical hypertensive status.
Multifactorial diseases occur in a complex biological context, and there is an increasing awareness of the importance of considering underlying biology when examining specific exposure-disease relations. Indeed, several recent studies highlighted effect modification in the relation between various predictors and disease outcomes (11–15). It is well known that the risk of hypertension varies with sex and obesity (15–20), and it is plausible that the observed benefit of marine food intake may differ by these characteristics. For example, the effects of EPA and DHA (10) may noticeably affect blood pressure in nonobese individuals, but may be overwhelmed by the milieu of metabolic dysfunction that accompanies obesity and therefore not have an impact in this context. Studies also suggest that the benefits of marine intake may vary by hypertension status (21, 22). Thus, the objective of the current analysis was to examine whether the inverse association between marine food intake and blood pressure is modified by sex, adiposity, and clinical hypertension status.
Methods
Participant recruitment and procedures.
Data are from the CANHR study, a cross-sectional, community-based participatory research study aimed at understanding the interaction of biological, genetic, nutritional, and psychosocial risk and protective factors for obesity and related disease in the Yup’ik people (23). The CANHR study protocol was approved by the University of Alaska Institutional Review Board, the National and Alaska Area Indian Health Service Institutional Review Board, and the Yukon-Kuskokwim Health Corporation Human Studies Committee.
The study protocol was described previously (4, 24). In brief, between 2003 and 2008, a convenience sample of men and women were recruited from 8 communities in the Yukon-Kuskokwim River Delta region of southwest Alaska. A total of 1003 individuals were enrolled in the study. Interested residents were invited to the local community center or other community building, where they completed a general interview covering demographic characteristics, educational level, ethnicity, and medical history. Clinical examinations were conducted for each participant to obtain anthropometric measurements (25). Blood samples were collected by venipuncture after at least 8 h of fasting, and certified interviewers conducted 24-h nutritional recall interviews (n = 547).
Biochemical assessment and dietary biomarker measurements.
Blood samples were processed locally into serum, lymphocyte, and RBC fractions by using a portable centrifuge and stored at −15°C in a portable freezer. Within 6 d, the samples were shipped to the University of Alaska Fairbanks and stored at −80°C (10). Blood samples were analyzed to obtain serum values for total cholesterol, HDL cholesterol, LDL cholesterol, glucose, and TGs, as described elsewhere (25).
RBC FAs were extracted with isopropanol and chloroform by using the procedure developed by Rose and Oklander (26), and FAMEs were analyzed by GC-LC, as described previously (27), to obtain individual FA concentrations, specifically DHA and EPA. RBC FA measurements were available for 497 of 1003 participants enrolled in the study.
The measurement of RBC stable nitrogen isotope ratios was completed at the Alaska Stable Isotope Facility at the University of Alaska Fairbanks, as described elsewhere (28, 29). Stable isotope ratios at natural abundance are expressed in permil (‰) abundance of 15N relative to an international standard: δ15N = (15N/14N sample – 15N/14Nstandard)/(15N/14Nstandard) · 1000‰, where the standard is atmospheric nitrogen (15N/14N = 0.003677) (28, 30). Stable isotope (δ15N) measurements were available for all 1003 participants who completed the CANHR 1 study (28).
Anthropometric measurements.
Trained staff completed anthropometric measurements with the use of protocols established by the NHANES III Anthropometric Procedures Manual, as described by Boyer et al. (24). Weight was measured to the nearest 0.1 kg. Standing height measurements were obtained to the nearest 1/8 inch. BMI was calculated by dividing weight (kg) by height (m2). Waist circumference measurements were obtained twice, immediately below the lateral portion of the rib cage, by using a Guilick II 150-cm tape measure (Rolyn Prest) with a tensioning device. If the difference between repeated measurements exceeded 2.0 cm, a third measurement was taken and recorded. Resting systolic and diastolic blood pressure values were measured 3 times after a 5-min rest period by using an Omron Hem-907 (Omron Healthcare) automated system; reported values are the mean of the 3 measurements (4, 24).
Dietary assessment.
Nutritional intake was assessed by using 24-h recall interviews (n = 547), as described in detail elsewhere (4, 24). In brief, participants were instructed to list all food and beverages consumed in a 24-h period, and the lead nutritionist reviewed all responses and followed up as necessary. Portion sizes were estimated by using methods developed by the Fred Hutchinson Cancer Research Center (4). A demographic/medical questionnaire was also administered that included questions on tobacco use.
Nutrient analysis was conducted by using the University of Minnesota’s Nutrition Data System for Research (NDS-R; software version 4.06, 2003) Food and Nutrient Database, which contains most traditional foods. If foods were missing from the databases, similar food items were substituted when appropriate or the missing item was added to the database. Appropriate calculations were made to obtain values for total fat intake (g/d), total energy intake (kJ), and total n–3 FA intake.
Inclusion criteria.
Nonnative individuals (n = 17) and participants who reported taking antihypertensive medications (n = 128) were excluded from the analysis, leaving 873 participants in the analysis. Nutritional intake information and RBC FA measurements were available for 466 and 451 of the 873 participants eligible for inclusion in the study, respectively. In addition, participants who were unable to recall ≥1 meals during the 24-h recall period (n = 8) and participants with improbable reported intake values (n = 27) were excluded from univariate analysis of the cohort’s nutrient intake; 4 participants with a total fat intake of >325 g/d and 23 participants with a caloric intake >5000 kcal/d or <600 kcal/d were excluded.
Statistical analysis.
BMI (in kg/m2) groups were established according to WHO guidelines: <18.5 = underweight, 18.5–24.9 = normal weight, 25.0–29.9 = overweight, and ≥30.0 = obese (31). Abdominal obesity was defined by using the WHO recommendations: ≥101.6 cm for men and ≥88.9 cm for women (32). Participants were classified as hypertensive according to the guidelines established by the NIH, National Heart, Lung, and Blood Institute: individuals having a systolic blood pressure >140 mm Hg or a diastolic blood pressure >90 mm Hg (33). We classified a participant as a tobacco user if he or she responded “yes” to any of the following 4 questions included in the demographic/medical questionnaire:
1) Have you smoked at least 100 cigarettes in your entire life?
2) Do you smoke regularly (>1 cigarette a day for the past 3 mo)?
3) Do you use chewing tobacco such as Redman Garret or iqmik (a form of smokeless tobacco used among Alaska Native people) (34)?
4) Do you use snuff such as Skoal or Copenhagen?
The primary outcomes of interest were systolic and diastolic blood pressure and the primary predictor of interest was the stable nitrogen isotope ratio (δ15N). To identify potential confounders, we first estimated unadjusted bivariate associations between the stable isotope ratio (δ15N) and participant characteristics including age and sex, anthropometric measurements, educational level, variables of nutritional intake, and blood pressure.
On the basis of these results, we constructed linear regression models with systolic or diastolic blood pressure as the outcomes, δ15N as the primary predictor, and age (continuous), sex, BMI (continuous), and educational level (continuous) as covariates. We conducted sensitivity analyses to evaluate the impact of tobacco use, total fat intake, total caloric intake, and RBC total cholesterol by individually adding these into the adjusted models. We also examined the potential nonlinear association of δ15N with systolic and diastolic blood pressure by modeling δ15N quartile groups with the first quartile (0–25%) as the reference group. We subsequently conducted a test for trend by modeling the δ15N quartiles as a single ordinal predictor and conducting a Wald test on the coefficient.
We conducted additional analysis to evaluate the interactions of participant characteristics and the stable isotope ratio on both systolic and diastolic blood pressure. We separately stratified the study cohort by sex, BMI group (excluding underweight), abdominal obesity, and clinical hypertension status. We then constructed adjusted linear regressions to evaluate the association between δ15N and blood pressure by stratum. We performed a likelihood ratio test to evaluate the interaction of δ15N and each stratified variable (e.g., sex). In sensitivity analyses, each model was subsequently adjusted for cholesterol intake, total fat intake, tobacco use, and combined RBC concentration of EPA and DHA.
Last, we examined whether the results we observed using δ15N were consistent with those found using combined RBC concentration of EPA and DHA as the predictor of interest. We repeated the adjusted linear regressions as well as the likelihood ratio tests described in the preceding paragraph, replacing δ15N with the combined RBC concentration of EPA and DHA.
All statistical tests were evaluated with a P = 0.05 significance level. All statistical analysis was performed by using Statistical Analysis Software (version 9.3l; SAS Institute).
Results
Participant characteristics
Of the 873 participants included in our analysis, 56% were overweight or obese, 47.5% were male, and 7% were classified as clinically hypertensive on the basis of their measured systolic or diastolic blood pressure. Participant characteristics stratified by BMI group, sex, and hypertensive status are shown in Table 1 and Supplemental Tables 1 and 2, respectively. As shown in Table 1, self-reported energy and fat intake did not differ by weight status. The mean biomarkers of marine food intake (δ15N, RBC DHA, and RBC EPA) were significantly higher in overweight and obese participants than in those of normal weight. The mean systolic and diastolic blood pressures were also higher in overweight and obese participants.
TABLE 1.
Participant characteristics of adult Alaska Native (Yup’ik) people1
| Overall (n = 873) | Normal weight (n = 356) | Overweight (n = 271) | Obese (n = 221) | |
| Demographic characteristics | ||||
| Age, y | 34.4 ± 15.7 | 29.4 ± 15.3 | 37.1 ± 15.1*** | 38.5 ± 13.6*** |
| Tobacco users,2 n (%) | 742 (85.0) | 293 (82.3) | 238 (87.8) | 191 (86.4) |
| Education: last grade completed, y | 10.5 ± 2.6 | 10.3 ± 2.3 | 10.7 ± 2.7 | 10.8 ± 2.5* |
| Anthropometric measurements | ||||
| Weight, kg | 70.7 ± 15.8 | 59.8 ± 7.7 | 71.2 ± 7.8*** | 89.1 ± 15.5*** |
| Height, m | 1.62 ± 0.08 | 1.63 ± 0.08 | 1.62 ± 0.08** | 1.60 ± 0.09*** |
| Waist circumference, cm | 88.6 ± 14.2 | 77.5 ± 5.7 | 89.6 ± 6.8*** | 106.7 ± 11.5*** |
| BMI,3 kg/m | 27.1 ± 5.8 | 22.4 ± 1.6 | 27.2 ± 1.4*** | 34.9 ± 4.8*** |
| Nutritional intake3 | ||||
| Energy, kJ/d | 8310 ± 3600 | 8330 ± 3450 | 8160 ± 3940 | 8130 ± 3350 |
| Total fat, g/d | 81.6 ± 50.4 | 76.6 ± 46.0 | 85.3 ± 55.2 | 85.8 ± 50 |
| n–3 FA, g/d | 5.0 ± 7.8 | 3.8 ± 5.0 | 6.5 ± 10.8** | 5.0 ± 6.1 |
| RBC analytes | ||||
| Cholesterol,4 mg/dL | 212 ± 46.2 | 200 ± 45.2 | 222 ± 47.1*** | 221 ± 41.6*** |
| δ15N,4 ‰ | 9.0 ± 1.5 | 8.6 ± 1.3 | 9.2 ± 1.5*** | 9.3 ± 1.7*** |
| DHA,5 % total FAs | 6.2 ± 1.8 | 5.8 ± 1.7 | 6.4 ± 1.8** | 6.5 ± 1.9** |
| EPA,5 % total FAs | 2.3 ± 1.8 | 1.9 ± 1.4 | 2.6 ± 1.9*** | 2.6 ± 1.9*** |
| Blood pressure, mm Hg | ||||
| Diastolic blood pressure | 69.9 ± 9.8 | 66.2 ± 8.7 | 70.2 ± 9.2*** | 76.0 ± 8.9*** |
| Systolic blood pressure | 118 ± 13.3 | 116 ± 12.7 | 119 ± 12.3* | 121 ± 14.1*** |
Values are means ± SDs unless otherwise indicated. Two-sample, 2-tailed t tests were performed to assess the significance of differences in participant characteristics of both overweight and obese strata relative to normal weight. *,**,***Different from normal weight: *P < 0.05, **P < 0.01, ***P < 0.001. δ15N, nitrogen stable isotope ratio.
We classified a participant as a tobacco user if they responded “yes” to any of the 4 questions concerning tobacco use that were included in the demographic/medical questionnaire.
Values based on 431 participants with 24-h recall data (35 participants excluded for unreliable or implausible values).
Values based on 862 participants with RBC stable isotope measurements.
Values based on 451 participants with individual RBC FA data.
Men had a lower mean BMI than women (25.7 vs. 28.3) (Supplemental Table 1). On average, men had lower measured δ15N and RBC DHA and higher self-reported total energy and fat intake. Mean systolic blood pressure was higher among men than among women, whereas mean diastolic blood pressure was similar in both sexes.
Hypertensive participants had a mean BMI that was 2.4 units higher than nonhypertensive participants. They also had a mean waist circumference that was 7.1 cm larger. Although there was no difference in self-reported energy and fat intake by hypertensive status, hypertensive participants had higher mean δ15N and RBC DHA and EPA concentrations than did nonhypertensive participants.
Association of δ15N and blood pressure: complete cohort
After adjustments for sex, age (continuous), BMI (continuous), and education (continuous), both δ15N and combined RBC EPA and DHA were negatively associated with diastolic and systolic blood pressure (Table 2). The association between δ15N and blood pressure was not significantly altered after adjustment for tobacco use, self-reported total fat intake and total energy intake, and RBC total cholesterol (data not shown).
TABLE 2.
Association between δ15N percentiles and blood pressure in adult Alaska Native (Yup’ik) people1
| Systolic blood pressure |
Diastolic blood pressure |
|||
| Predictor | Change (mm Hg) per unit of predictor | P-trend | Change (mm Hg) per unit of predictor | P-trend |
| RBC EPA and DHA2 (%) | −0.4 (−0.9, 0.1) | −0.3 (−0.6, 0.1) | ||
| δ15N (‰) | −0.9 (−1.6, −0.3) | −0.6 (−1.1, −0.2) | ||
| δ15N quartiles | ||||
| 1 (<7.83‰) | 1.0 | 1.0 | ||
| 2 (7.83‰ to <8.71‰) | −0.6 (−2.9, 1.6) | −0.4 (−2.0, 1.3) | ||
| 3 (8.71–9.86‰) | −2.0 (−4.4, 0.4) | −0.1 (−1.9, 1.6) | ||
| 4 (>9.86‰) | −3.8 (−6.5, −1.2) | <0.01 | −2.3 (−4.2, −0.3) | <0.05 |
Values are β-coefficients (95% CIs) from linear regression models with systolic or diastolic blood pressure as the outcome and predictors that included δ15N or δ15N quartiles, age (continuous), sex, BMI (continuous), and educational level (continuous); n = 873. P values were from a test for linear trend where δ15N quartiles were fit as a single ordinal predictor. δ15N, nitrogen stable isotope ratio.
Values based on 451 participants with individual RBC FA data.
Quartiles of δ15N were linearly associated with systolic blood pressure (P-trend < 0.01); participants in the fourth quartile of δ15N had a systolic blood pressure that was 3.8 mm Hg lower than those in the first quartile (95% CI: −6.5, −1.2 mm Hg). The linearity of the association between δ15N and diastolic blood pressure was less prominent (P-trend < 0.05).
Effect modification
δ15N and systolic blood pressure.
The association between δ15N and systolic blood pressure was modified by BMI and abdominal obesity status, sex, and hypertensive status (Table 3). Although each permil increase in δ15N was associated with a −1.5 to −1.7 mm Hg lower systolic blood pressure in normal-weight and overweight participants, there was no association in obese participants (P-interaction < 0.0001). Similarly, in non–abdominally obese participants, each permil increase in δ15N was associated with a −1.6 mm Hg (95% CI: −2.4, −0.9 mm Hg) difference in mean systolic blood pressure, whereas there was no observed association in abdominally obese individuals (P-interaction < 0.0001). The association of δ15N with systolic blood pressure also varied substantially by sex: each permil increase in δ15N was associated with a 1.5-mm Hg decrease (95% CI: −2.4, −0.6 mm Hg) in mean systolic blood pressure in men, although no association was observed in women (P-interaction < 0.0001). In analyses stratified by participant hypertension status, δ15N showed an inverse association in nonhypertensive individuals only (P-interaction < 0.05); each permil increase in δ15N was associated with a −0.6 mm Hg (95% CI: −1.2, 0.0 mm Hg) difference in mean systolic blood pressure in this stratum.
TABLE 3.
Associations of δ15N, a marker of marine food intake, and blood pressure in adult Alaska Native (Yup’ik) people1
| Stratified analysis | Systolic blood pressure | Diastolic blood pressure |
| Sex | ||
| Men (n = 408) | −1.5 (−2.4, −0.6) | −0.7 (−1.4, 0.0) |
| Women (n = 449) | −0.6 (−1.5, 0.3) | −0.6 (−1.2, 0.0) |
| P-interaction2 | <0.0001 | 0.4 |
| BMI group3 | ||
| Normal (n = 356) | −1.5 (−2.6, −0.5) | −1.1 (−1.9, −0.3) |
| Overweight (n = 269) | −1.7 (−2.8, −0.5) | −1.0 (−1.9, −0.1) |
| Obese (n = 221) | 0.3 (−0.9, 1.5) | 0.1 (−0.7, 1.0) |
| P-interaction | <0.0001 | < 0.05 |
| Abdominally obese4 | ||
| Not obese (n = 585) | −1.6 (−2.4, −0.9) | −1.1 (−1.7, −0.5) |
| Obese (n = 272) | 0.0 (−1.2, 1.2) | 0.0 (−0.8, 0.9) |
| P-interaction | <0.0001 | 0.4 |
| Hypertensive5 | ||
| No (n = 796) | −0.6 (−1.2, 0.0) | −0.7 (−1.1, −0.2) |
| Yes (n = 61) | 0.1 (−2.0, 2.1) | 0.7 (−0.9, 2.3) |
| P-interaction | <0.05 | 0.2 |
Values are β-coefficients (95% CIs) from linear regression models, stratified by participant characteristics (as listed) with systolic blood pressure as the outcome and predictors that included δ15N, age (continuous), education (continuous), sex (where applicable), and BMI [(continuous); where applicable]; n = 873. δ15N, nitrogen stable isotope ratio.
P-interaction values were derived from a likelihood ratio test of interaction.
BMI (in kg/m2) groups were defined according to WHO guidelines: <18.5 = underweight, 18.5–24.9 = normal weight, 25.0–29.9 = overweight, and ≥30.0 = obese; underweight participants were excluded from the analysis.
Abdominal obesity was defined by using the WHO recommendations: ≥101.6 cm for men and ≥88.9 cm for women.
Participants having a systolic blood pressure >140 mm Hg or a diastolic blood pressure >90 mm Hg were classified as hypertensive.
δ15N and diastolic blood pressure.
The association between δ15N and diastolic blood pressure was modified by obesity status (Table 3). Each permil increase in δ15N was associated with a −1.1-mm Hg (95% CI: −1.9, −0.3 mm Hg) and a −1.0-mm Hg (95% CI: −1.9, −0.1 mm Hg) difference in normal-weight and overweight participants, respectively, whereas no association was observed in obese participants (P-interaction < 0.05). In addition, an inverse association between δ15N and diastolic blood pressure was observed only in the non–abdominally obese stratum, although the interaction did not reach statistical significance. When stratifying by hypertension status, δ15N showed an inverse association in nonhypertensive individuals only, although the interaction was not statistically significant. No interaction was observed when examining participants stratified by sex.
Adjustment for RBC concentrations of EPA and DHA attenuated the associations in the stratified subgroups. With the exception of diastolic blood pressure in non–abdominally obese participants, the association between δ15N and blood pressure was not significant in all subgroups, although the directions of the associations were consistent (data not shown).
Associations between combined RBC concentration of EPA and DHA and blood pressure
The results observed by using δ15N were consistent with those obtained by using the combined RBC concentration of EPA and DHA as our predictor of interest (Table 4). An inverse association between combined RBC concentration of EPA and DHA and systolic blood pressure was observed in the male (P-interaction < 0.001) and non–abdominally obese (P-interaction < 0.01) strata. No interaction was observed when examining participants stratified by BMI group, although the direction of the association is consistent with that observed with δ15N. No significant effect modification was observed when examining the association between combined RBC concentration of EPA and DHA and diastolic blood pressure, although the direction of the associations was consistent with those obtained by using δ15N.
TABLE 4.
Associations of combined RBC concentrations of EPA and DHA and blood pressure in adult Alaska Native (Yup’ik) people1
| Stratified analysis | Systolic blood pressure | Diastolic blood pressure |
| Sex | ||
| Men (n = 408) | −0.7 (−1.4, 0.0) | −0.5 (−1.0, 0.0) |
| Women (n = 449) | −0.2 (−0.8, 0.5) | −0.1 (−0.5, 0.4) |
| P-interaction2 | <0.001 | 0.9 |
| BMI group3 | ||
| Normal (n = 356) | −0.7 (−1.5, 0.1) | −0.5 (−1.2, 0.1) |
| Overweight (n = 269) | −0.5 (−1.3, 0.3) | −0.4 (−1.0, 0.2) |
| Obese (n = 221) | 0.3 (−0.7, 1.2) | 0.1 (−0.5, 0.7) |
| P-interaction | 0.2 | 0.2 |
| Abdominally obese4 | ||
| Not obese (n = 585) | −0.7 (−1.2, −0.1) | −0.5 (−0.9, −0.1) |
| Obese (n = 272) | 0.0 (−0.9, 0.9) | 0.0 (−0.6, 0.6) |
| P-interaction | <0.01 | 0.8 |
| Hypertensive5 | ||
| No (n = 796) | −0.2 (−0.6, 0.1) | −0.3 (−0.6, 0.1) |
| Yes (n = 61) | −0.1 (−2.0, 1.8) | 0.0 (−1.1, 1.1) |
| P-interaction | <0.05 | 0.1 |
Values are β-coefficients (95% CIs) from linear regression models based on 451 participants with individual RBC FA data, stratified by participant characteristics (as listed) with systolic blood pressure as the outcome and predictors that included RBC EPA and DHA intake, age (continuous), education (continuous), sex (where applicable), and BMI [(continuous); where applicable]; total n = 873.
P-interaction values were derived from a likelihood ratio test of interaction.
BMI (in kg/m2) groups were defined according to WHO guidelines: <18.5 = underweight, 18.5–24.9 = normal weight, 25.0–29.9 = overweight, and ≥30.0 = obese; underweight participants were excluded from the analysis.
Abdominal obesity was defined by using the WHO recommendations: ≥101.6 cm for men and ≥88.9 cm for women.
Participants having a systolic blood pressure >140 mm Hg or a diastolic blood pressure >90 mm Hg were classified as hypertensive.
Discussion
The nitrogen stable isotope ratio is a marker of marine protein intake, which is correlated with intakes of EPA, DHA, and marine foods. Given its broad association with marine food intake, δ15N could capture aspects of marine intake beyond marine protein, such as other macro- and micronutrients. We observed an inverse association between marine food intake and blood pressure, which was modified by participant characteristics. Specifically, the inverse association of marine food intake with systolic blood pressure was observed only in male, nonobese, and nonhypertensive participants, and the inverse effect on diastolic blood pressure was observed only in nonobese individuals.
Clinical trials in general US and European populations (21, 22, 35) as well as with the observational findings from the Genetic of Coronary Artery Disease in Alaskan Natives study (36) found a protective association between marine food intake and blood pressure, although few studies explored whether this association is modified by participant characteristics.
In this Yup’ik study population, the inverse association between marine food intake and diastolic blood pressure was observed in both men and women. However, marine food intake was associated only with systolic blood pressure in men. Surprisingly, modification of the association between marine food intake and blood pressure by sex has been largely unexplored in the literature, and many relevant clinical trials focus only on men (21, 22). In a meta-regression analysis by Geleijnse et al. (37) of 36 trials, the association of fish oil with systolic and diastolic blood pressure was not statistically different in trials that included men and women compared with those that included only men; however, the authors stated that they could not effectively evaluate effect modification by sex because of the lack of randomized trials in women and the lack of sex-stratified results in trial reports. A study in an adult Inuit population (n = 1861) from Greenland did look at marine food intake and blood pressure stratified by sex (38). In this study population, whole-blood mercury concentration (another biomarker of marine food intake) was associated with a decrease in diastolic blood pressure in men, whereas no significant association was observed among women; the authors did not conduct a statistical test for interaction.
The biological mechanism by which marine food intake could differentially affect men and women is unknown. It is possible that EPA- and DHA-mediated release of the vasodilator NO may vary by sex, as was observed in previous studies in rabbits (39) and rats (40, 41). Studies by McCulloch and Randall (42), Villar et al. (43), Scotland et al. (44), and Pak et al. (45) suggest that NO is the predominant mediator of vasodilation in men, whereas vasodilation in women seems to be primarily regulated by endothelium-derived hyperpolarizing factor (EDRF). If marine food intake differentially affects NO and EDRF release, then it is possible that marine intake may differentially affect blood pressure in males and females.
In this study population, the inverse association between marine food intake and systolic blood pressure was observed only in individuals with nonobese BMIs and waist circumferences compared with those with obese levels of overall and central adiposity. Although most studies on marine food intake and blood pressure controlled for adiposity, we are not aware of any other studies that tested for effect modification by obesity status. The Geleijnse et al. (37) meta-regression analysis on fish oil and blood pressure attempted to explore this question by comparing 20 trials in participants with a BMI >26.8 to 7 trials in participants with a BMI ≤26.8; they did not observe a significant difference in effect size between these 2 groups of trials. Although provocative, this meta-regression analysis is limited by its inability to examine associations on an individual level. Effect modification by obesity status is plausible given that adipose tissue produces adipokines and inflammatory cytokines, including IL-6 (46) and adiponectin (47), which affect vasoconstriction (48). It is possible that these adipose-derived products modify the association between marine food intake and blood pressure. In addition, obesity is a strong independent risk factor for hypertension (15, 19, 20) and the harmful effects of obesity on blood pressure may overwhelm the inverse effects of increased marine food intake.
In this study, we observed an inverse association between marine food intake and blood pressure in nonhypertensive individuals. An association in nonhypertensive individuals has been identified in a number of randomized controlled trials, although several studies observed a larger effect of n–3 supplementation in hypertensive individuals (21, 22, 37). Although we only observed the inverse association of marine food intake with blood pressure in nonhypertensive individuals, we cannot rule out an inverse association in hypertensive individuals given the limited number of individuals with clinical hypertension (n = 61) included in our analysis.
This study has several key strengths and limitations. The unique study population had 50-fold variability in PUFA intake and the mean intake of EPA and DHA was 20 times higher than that of the general US population (49), allowing for the identification of novel findings that could broaden our understanding of the incidence of hypertension in general. Moreover, we used an objective biomarker of marine food intake to explore effect modification by individual characteristics. Our study was limited by its observational design, and thus we could not determine causality or exclude the possibility of confounding from other dietary components that are associated with a traditional lifestyle. Moreover, the small number of uncontrolled hypertensive individuals in our study cohort limited our power to examine the association between marine food intake and blood pressure in this group. In addition, although δ15N is highly correlated with overall marine food intake, our study could not specifically explore which nutritional components of marine food intake are protective. In addition, future work should assess the impact of other components of the Yup’ik diet (e.g., berry consumption, sodium intake) and lifestyle factors (e.g., level of physical activity) that may confer additional health benefits and/or potentially confound our observed associations. Given the high incidence and lack of variability in tobacco use in our study cohort, we were also unable to appropriately evaluate the effect of tobacco use on the associations we observed. Our findings need to be replicated in other cohorts of Alaska Native people, and clinical prospective studies could be conducted within this population. Future studies should also examine whether δ15N interacts with obesity and hypertension to determine other outcomes, including blood TGs, cholesterol, insulin, and glucose.
Our findings have important implications for both our general understanding of dietary effects on hypertension and Alaska Native health. Our results suggest that the large amount of marine foods in the traditional Yup’ik diet has beneficial effects on blood pressure, and this inverse association may be most pronounced in nonobese individuals. Importantly, we also observed an inverse association between marine food intake and blood pressure in nonhypertensive individuals, a group that incurs the majority of cardiovascular events (50). The modifications we observed underline the importance of considering effect modification in future studies in the field.
In conclusion, we found that the inverse association of marine food intake with systolic and diastolic blood pressure was greater in nonobese individuals. We also found a larger inverse association between marine food intake and systolic blood pressure in men than in women.
Supplementary Material
Acknowledgments
We thank Jynene Black (technician) and Eliza Orr (cultural consultant). BRB-J, DMO, SEH, BBB, and DG-D designed and conducted the research; BRB-J and DG-D analyzed the data or performed statistical analysis, wrote the manuscript, and had primary responsibility for final content; and DMO, SEH, JHM, and BBB provided extensive feedback on the written manuscript. All authors read and approved the final version of the manuscript.
References
- 1.McLaughlin JB, Middaugh JP, Utermohle CJ, Asay ED, Fenaughty AM, Eberhart-Phillips JE. Changing patterns of risk factors and mortality for coronary heart disease among Alaska Natives, 1979–2002. JAMA 2004;291:2545–6. [DOI] [PubMed] [Google Scholar]
- 2.Murphy NJ, Schraer CD, Theile MC, Boyko EJ, Bulkow LR, Doty BJ, Lanier AP. Hypertension in Alaska Natives: association with overweight, glucose intolerance, diet and mechanized activity. Ethn Health 1997;2:267–75. [DOI] [PubMed] [Google Scholar]
- 3.Corcoran AC. Serum-cholesterol levels and blood-pressure of Alaskan Eskimo men. Lancet 1958;272:1122. [DOI] [PubMed] [Google Scholar]
- 4.Bersamin A, Luick BR, King IB, Stern JS, Zidenberg-Cherr S. Westernizing diets influence fat intake, red blood cell fatty acid composition, and health in remote Alaskan Native communities in the center for Alaska Native Health Study. J Am Diet Assoc 2008;108:266–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bersamin A, Zidenberg-Cherr S, Stern JS, Luick BR. Nutrient intakes are associated with adherence to a traditional diet among Yup'ik Eskimos living in remote Alaska Native communities: the CANHR study. Int J Circumpolar Health 2007;66:62–70. [DOI] [PubMed] [Google Scholar]
- 6.Makhoul Z, Kristal AR, Gulati R, Luick B, Bersamin A, Boyer B, Mohatt GV. Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos. Am J Clin Nutr 2010;91:777–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004;27:2444–9. [DOI] [PubMed] [Google Scholar]
- 8.Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet 2009;125:507–25. [DOI] [PubMed] [Google Scholar]
- 9.Miller AB, Linseisen J. Achievements and future of nutritional cancer epidemiology. Int J Cancer 2010;126:1531–7. [DOI] [PubMed] [Google Scholar]
- 10.O'Brien DM, Kristal AR, Nash SH, Hopkins SE, Luick BR, Stanhope KL, Havel PJ, Boyer BB. A stable isotope biomarker of marine food intake captures associations between n–3 fatty acid intake and chronic disease risk in a Yup'ik study population, and detects new associations with blood pressure and adiponectin. J Nutr 2014;144:706–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.McCarthy JJ, Meyer J, Moliterno DJ, Newby LK, Rogers WJ, Topol EJ. Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum Genet 2003;114:87–98. [DOI] [PubMed] [Google Scholar]
- 12.Jakobsen MU, Overvad K, Dyerberg J, Schroll M, Heitmann BL. Dietary fat and risk of coronary heart disease: possible effect modification by gender and age. Am J Epidemiol 2004;160:141–9. [DOI] [PubMed] [Google Scholar]
- 13.El Khoudary SR, Wildman RP, Matthews K, Powell L, Hollenberg SM, Edmundowicz D, Sutton-Tyrrell K. Effect modification of obesity on associations between endogenous steroid sex hormones and arterial calcification in women at midlife. Menopause 2011;18:906–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nurmatov U, Nwaru BI, Devereux G, Sheikh A. Confounding and effect modification in studies of diet and childhood asthma and allergies. Allergy 2012;67:1041–59. [DOI] [PubMed] [Google Scholar]
- 15.Kurukulasuriya LR, Stas S, Lastra G, Manrique C, Sowers JR. Hypertension in obesity. Med Clin North Am 2011;95:903–17. [DOI] [PubMed] [Google Scholar]
- 16.Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension 2008;52:818–27. [DOI] [PubMed] [Google Scholar]
- 17.Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004;44:398–404. [DOI] [PubMed] [Google Scholar]
- 18.Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM. The relation of adiposity to blood pressure and development of hypertension: the Framingham study. Ann Intern Med 1967;67:48–59. [DOI] [PubMed] [Google Scholar]
- 19.Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, Herrington DM. The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens 2011;25:73–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Berchtold P, Jorgens V, Finke C, Berger M. Epidemiology of obesity and hypertension. Int J Obes 1981;5:1–7. [PubMed] [Google Scholar]
- 21.Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523–33. [DOI] [PubMed] [Google Scholar]
- 22.Appel LJ, Miller ER III, Seidler AJ, Whelton PK. Does supplementation of diet with 'fish oil’ reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429–38. [PubMed] [Google Scholar]
- 23.Mohatt GV, Plaetke R, Klejka J, Luick B, Lardon C, Bersamin A, Hopkins S, Dondanville M, Herron J, Boyer B. The Center for Alaska Native Health Research Study: a community-based participatory research study of obesity and chronic disease-related protective and risk factors. Int J Circumpolar Health 2007;66:8–18. [DOI] [PubMed] [Google Scholar]
- 24.Boyer BB, Mohatt GV, Lardon C, Plaetke R, Luick BR, Hutchison SH, de Mayolo GA, Ruppert E, Bersamin A. Building a community-based participatory research center to investigate obesity and diabetes in Alaska Natives. Int J Circumpolar Health 2005;64:281–90. [DOI] [PubMed] [Google Scholar]
- 25.Boyer BB, Mohatt GV, Plaetke R, Herron J, Stanhope KL, Stephensen C, Havel PJ, Team CP. Metabolic syndrome in Yup'ik Eskimos: the Center for Alaska Native Health Research (CANHR) Study. Obesity (Silver Spring) 2007;15:2535–40. [DOI] [PubMed] [Google Scholar]
- 26.Rose HG, Oklander M. Improved procedure for the extraction of lipids from human erythrocytes. J Lipid Res 1965;6:428–31. [PubMed] [Google Scholar]
- 27.King IB, Lemaitre RN, Kestin M. Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. Am J Clin Nutr 2006;83:227–36. [DOI] [PubMed] [Google Scholar]
- 28.Nash SH, Bersamin A, Kristal AR, Hopkins SE, Church RS, Pasker RL, Luick BR, Mohatt GV, Boyer BB, O'Brien DM. Stable nitrogen and carbon isotope ratios indicate traditional and market food intake in an indigenous circumpolar population. J Nutr 2012;142:84–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.O'Brien DM, Kristal AR, Jeannet MA, Wilkinson MJ, Bersamin A, Luick B. Red blood cell delta15N: a novel biomarker of dietary eicosapentaenoic acid and docosahexaenoic acid intake. Am J Clin Nutr 2009;89:913–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Nash SH, Kristal AR, Bersamin A, Hopkins SE, Boyer BB, O'Brien DM. Carbon and nitrogen stable isotope ratios predict intake of sweeteners in a Yup'ik study population. J Nutr 2013;143:161–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee 1995. World Health Organ Tech Rep Ser. No.: 854. [PubMed]
- 32.Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433–8. [DOI] [PubMed] [Google Scholar]
- 33.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Masterson BJ, Oparil S, Wright JT Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–52. [DOI] [PubMed] [Google Scholar]
- 34.Renner CC, Enoch C, Patten CA, Ebbert JO, Hurt RD, Moyer TP, Provost EM. Iqmik: a form of smokeless tobacco used among Alaska natives. Am J Health Behav 2005;29:588–94. [DOI] [PubMed] [Google Scholar]
- 35.Miller PE, Van Elswyk M, Alexander DD. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens 2014;27:885–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ebbesson SO, Tejero ME, Nobmann ED, Lopez-Alvarenga JC, Ebbesson L, Romenesko T, Carter EA, Resnick HE, Devereux RB, MacCluer JW, et al. Fatty acid consumption and metabolic syndrome components: the GOCADAN study. J Cardiometab Syndr 2007;2:244–9. [DOI] [PubMed] [Google Scholar]
- 37.Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002;20:1493–9. [DOI] [PubMed] [Google Scholar]
- 38.Nielsen AB, Davidsen M, Bjerregaard P. The association between blood pressure and whole blood methylmercury in a cross-sectional study among Inuit in Greenland. Environ Health 2012;11:44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sánchez A, Gomez MJ, Dorantes AL, Rosales JL, Pastelin G, Diaz V, Posadas F, Escalante B. The effect of ovariectomy on depressed contractions to phenylephrine and KCl and increased relaxation to acetylcholine in isolated aortic rings of female compared to male rabbits. Br J Pharmacol 1996;118:2017–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Huang A, Sun D, Koller A, Kaley G. Gender difference in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO. Am J Physiol 1997;272:H1804–9. [DOI] [PubMed] [Google Scholar]
- 41.Kauser K, Rubanyi GM. Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol 1994;267:H2311–7. [DOI] [PubMed] [Google Scholar]
- 42.McCulloch AI, Randall MD. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed. Br J Pharmacol 1998;123:1700–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Villar IC, Hobbs AJ, Ahluwalia A. Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor. J Endocrinol 2008;197:447–62. [DOI] [PubMed] [Google Scholar]
- 44.Scotland RS, Madhani M, Chauhan S, Moncada S, Andresen J, Nilsson H, Hobbs AJ, Ahluwalia A. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 2005;111:796–803. [DOI] [PubMed] [Google Scholar]
- 45.Pak KJ, Geary GG, Duckles SP, Krause DN. Male-female differences in the relative contribution of endothelial vasodilators released by rat tail artery. Life Sci 2002;71:1633–42. [DOI] [PubMed] [Google Scholar]
- 46.Farb MG, Ganley-Leal L, Mott M, Liang Y, Ercan B, Widlansky ME, Bigornia SJ, Fiscale AJ, Apovian CM, Carmine B, et al. Arteriolar function in visceral adipose tissue is impaired in human obesity. Arterioscler Thromb Vasc Biol 2012;32:467–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Lynch FM, Withers SB, Yao Z, Werner ME, Edwards G, Weston AH, Heagerty AM. Perivascular adipose tissue-derived adiponectin activates BK(Ca) channels to induce anticontractile responses. Am J Physiol Heart Circ Physiol 2013;304:H786–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Owen MK, Witzmann FA, McKenney ML, Lai X, Berwick ZC, Moberly SP, Alloosh M, Sturek M, Tune JD. Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation 2013;128:9–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Lemas DJ, Klimentidis YC, Wiener HH, O'Brien DM, Hopkins SE, Allison DB, Fernandez JR, Tiwari HK, Boyer BB. Obesity polymorphisms identified in genome-wide association studies interact with n-3 polyunsaturated fatty acid intake and modify the genetic association with adiposity phenotypes in Yup'ik people. Genes Nutr 2013;8:495–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993;153:598–615. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
